<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Li W</submitter><funding>Fundamental research program funding of Ninth People's Hospital affiliated to Shanghai Jiao Tong University School of Medicine</funding><funding>National Natural Science Foundation of China</funding><pagination>e70070</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12003102</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>14(4)</volume><pubmed_abstract>Only a minority of patients with head and neck squamous cell carcinoma (HNSCC) respond favourably to immunotherapy. The oral oncogenic bacterium Fusobacterium nucleatum (F.nucleatum) was recently observed to suppress the anti-tumour immune response, although the mechanisms remain unclear. In this study, we found that outer membrane vesicles (OMVs) derived from F.nucleatum (F.n-OMVs) promoted HNSCC progression by inducing immunosuppressive phenotypes of tumour-associated macrophages (TAMs), resulting in decreased cytotoxic T lymphocyte infiltration in vivo. Mechanistically, TAMs internalized tryptophanase presented in F.n-OMVs, which activated the tryptophan-2,3-dioxygenase 2/aryl hydrocarbon receptor (TDO2/AHR) pathway and upregulated the transcription of immunosuppressive cytokines and im</pubmed_abstract><journal>Journal of extracellular vesicles</journal><pubmed_title>Fusobacterium nucleatum-Derived Outer Membrane Vesicles Promote Immunotherapy Resistance via Changes in Tryptophan Metabolism in Tumour-Associated Macrophages.</pubmed_title><pmcid>PMC12003102</pmcid><funding_grant_id>82173217</funding_grant_id><funding_grant_id>JYZZ180</funding_grant_id><funding_grant_id>82230090</funding_grant_id><funding_grant_id>82373352</funding_grant_id><pubmed_authors>Li W</pubmed_authors><pubmed_authors>Yan M</pubmed_authors><pubmed_authors>Mao M</pubmed_authors><pubmed_authors>Zhang Z</pubmed_authors><pubmed_authors>Chen W</pubmed_authors><pubmed_authors>Wu R</pubmed_authors><pubmed_authors>Ji Y</pubmed_authors><pubmed_authors>Wang X</pubmed_authors><pubmed_authors>Dou S</pubmed_authors></additional><is_claimable>false</is_claimable><name>Fusobacterium nucleatum-Derived Outer Membrane Vesicles Promote Immunotherapy Resistance via Changes in Tryptophan Metabolism in Tumour-Associated Macrophages.</name><description>Only a minority of patients with head and neck squamous cell carcinoma (HNSCC) respond favourably to immunotherapy. The oral oncogenic bacterium Fusobacterium nucleatum (F.nucleatum) was recently observed to suppress the anti-tumour immune response, although the mechanisms remain unclear. In this study, we found that outer membrane vesicles (OMVs) derived from F.nucleatum (F.n-OMVs) promoted HNSCC progression by inducing immunosuppressive phenotypes of tumour-associated macrophages (TAMs), resulting in decreased cytotoxic T lymphocyte infiltration in vivo. Mechanistically, TAMs internalized tryptophanase presented in F.n-OMVs, which activated the tryptophan-2,3-dioxygenase 2/aryl hydrocarbon receptor (TDO2/AHR) pathway and upregulated the transcription of immunosuppressive cytokines and im</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Apr</publication><modification>2026-06-02T06:41:41.607Z</modification><creation>2026-05-25T03:07:48.762Z</creation></dates><accession>S-EPMC12003102</accession><cross_references><pubmed>40241230</pubmed><doi>10.1002/jev2.70070</doi></cross_references></HashMap>